Pharvaris
Amy DeWerth is currently the Director, Regional Clinical Lead at Pharvaris. Amy has held various roles in the pharmaceutical industry, including Strategic Account Lead at The Janssen Pharmaceutical Companies of Johnson & Johnson and Director, Clinical Site Liaison at Momenta Pharmaceuticals. With a background in education and counseling, Amy has also worked in roles such as Group Leader at REGISTRAT MAPI and Clinical Manager at United Bio Source Inc. Amy's extensive experience includes positions such as Site Manager, Clinical Rater, and Clinical Research Coordinator at Suburban Research Associates.
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.